Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 2236

1.

Discovering the pharmacodynamics of conolidine and cannabidiol using a cultured neuronal network based workflow.

Mendis GDC, Berecki G, Morrisroe E, Pachernegg S, Li M, Varney M, Osborne PB, Reid CA, Halgamuge S, Petrou S.

Sci Rep. 2019 Jan 15;9(1):121. doi: 10.1038/s41598-018-37138-w.

2.

Cannabis and Mood Disorders.

Lucatch AM, Coles AS, Hill KP, George TP.

Curr Addict Rep. 2018 Sep;5(3):336-345. doi: 10.1007/s40429-018-0214-y. Epub 2018 May 10.

PMID:
30643708
3.

A preliminary investigation of lung availability of cannabinoids by smoking marijuana or dabbing BHO and decarboxylation rate of THC- and CBD-acids.

Hädener M, Vieten S, Weinmann W, Mahler H.

Forensic Sci Int. 2019 Jan 6. pii: S0379-0738(18)30847-8. doi: 10.1016/j.forsciint.2018.12.021. [Epub ahead of print]

PMID:
30638755
4.

9-Tetrahydrocannabinol, a major marijuana component, enhances the anesthetic effect of pentobarbital through the CB1 receptor.

Kimura T, Takaya M, Usami N, Watanabe K, Yamamoto I.

Forensic Toxicol. 2019;37(1):207-214. doi: 10.1007/s11419-018-0457-2. Epub 2018 Nov 24.

5.

Preclinical safety and efficacy of cannabidivarin for early life seizures.

Huizenga MN, Sepulveda-Rodriguez A, Forcelli PA.

Neuropharmacology. 2019 Jan 8. pii: S0028-3908(18)30678-6. doi: 10.1016/j.neuropharm.2019.01.002. [Epub ahead of print]

PMID:
30633929
6.

Cannabis sativa L. and Nonpsychoactive Cannabinoids: Their Chemistry and Role against Oxidative Stress, Inflammation, and Cancer.

Pellati F, Borgonetti V, Brighenti V, Biagi M, Benvenuti S, Corsi L.

Biomed Res Int. 2018 Dec 4;2018:1691428. doi: 10.1155/2018/1691428. eCollection 2018. Review.

7.

Special Considerations and Assessment in Patients with Multiple Sclerosis.

Maitin IB, Cruz E.

Phys Med Rehabil Clin N Am. 2018 Aug;29(3):473-481. doi: 10.1016/j.pmr.2018.03.003. Epub 2018 May 8. Review.

PMID:
30626509
8.

Cannabidiol in Anxiety and Sleep: A Large Case Series.

Shannon S, Lewis N, Lee H, Hughes S.

Perm J. 2019;23. pii: 18-041. doi: 10.7812/TPP/18-041.

9.

Why marijuana is headed for the mainstream.

Reinke T.

Manag Care. 2018 Dec;27(12):31.

10.

Epidiolex (Cannabidiol): A New Hope for Patients With Dravet or Lennox-Gastaut Syndromes.

Chen JW, Borgelt LM, Blackmer AB.

Ann Pharmacother. 2019 Jan 8:1060028018822124. doi: 10.1177/1060028018822124. [Epub ahead of print]

PMID:
30616356
11.

Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids.

Brook E, Mamo J, Wong R, Al-Salami H, Falasca M, Lam V, Takechi R.

Pharmacol Res. 2019 Jan 4;141:291-297. doi: 10.1016/j.phrs.2019.01.009. [Epub ahead of print] Review.

PMID:
30616019
12.

Validation of a liquid chromatography-tandem mass spectrometry method for analyzing cannabinoids in oral fluid.

Sobolesky PM, Smith BE, Hubbard JA, Stone J, Fitzgerald RL.

Clin Chim Acta. 2019 Jan 4. pii: S0009-8981(19)30002-6. doi: 10.1016/j.cca.2019.01.002. [Epub ahead of print]

PMID:
30615854
13.

Cannabinoid concentrations in confiscated cannabis samples and in whole blood and urine after smoking CBD-rich cannabis as a "tobacco substitute".

Hädener M, Gelmi TJ, Martin-Fabritius M, Weinmann W, Pfäffli M.

Int J Legal Med. 2019 Jan 5. doi: 10.1007/s00414-018-01994-y. [Epub ahead of print]

PMID:
30612324
14.

Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ9-Tetrahydrocannabinol-Induced Cognitive Impairment.

Aso E, Fernández-Dueñas V, López-Cano M, Taura J, Watanabe M, Ferrer I, Luján R, Ciruela F.

Mol Neurobiol. 2019 Jan 4. doi: 10.1007/s12035-018-1456-3. [Epub ahead of print]

PMID:
30610611
15.

Tempering aversive/traumatic memories with cannabinoids: a review of evidence from animal and human studies.

Lisboa SF, Vila-Verde C, Rosa J, Uliana DL, Stern CAJ, Bertoglio LJ, Resstel LB, Guimaraes FS.

Psychopharmacology (Berl). 2019 Jan 2. doi: 10.1007/s00213-018-5127-x. [Epub ahead of print] Review.

PMID:
30604182
16.

Cannabidiol.

Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006-.

17.

Cannabidiol Affects Extracellular Vesicle Release, miR21 and miR126, and Reduces Prohibitin Protein in Glioblastoma Multiforme Cells.

Kosgodage US, Uysal-Onganer P, MacLatchy A, Mould R, Nunn AV, Guy GW, Kraev I, Chatterton NP, Thomas EL, Inal JM, Bell JD, Lange S.

Transl Oncol. 2018 Dec 28;12(3):513-522. doi: 10.1016/j.tranon.2018.12.004. [Epub ahead of print]

18.

The Anti-Inflammatory Properties of Terpenoids from Cannabis.

Gallily R, Yekhtin Z, Hanuš LO.

Cannabis Cannabinoid Res. 2018 Dec 26;3(1):282-290. doi: 10.1089/can.2018.0014. eCollection 2018.

19.

Successful use of pure cannabidiol for the treatment of super-refractory status epilepticus.

Rajaraman RR, Sankar R, Hussain SA.

Epilepsy Behav Case Rep. 2018 Jul 17;10:141-144. doi: 10.1016/j.ebcr.2018.07.004. eCollection 2018.

20.

Multigenerational consequences of early-life cannabinoid exposure in zebrafish.

Carty DR, Miller ZS, Thornton C, Pandelides Z, Kutchma ML, Willett KL.

Toxicol Appl Pharmacol. 2019 Feb 1;364:133-143. doi: 10.1016/j.taap.2018.12.021. Epub 2018 Dec 27.

PMID:
30594692

Supplemental Content

Loading ...
Support Center